172 related articles for article (PubMed ID: 35411132)
1. Targets Exploration of Hydroxychloroquine for Pigmentation and Cell Protection Effect in Melanocytes: The Clue for Vitiligo Treatment.
Xie B; Chen Y; Hu Y; Zhao Y; Luo H; Xu J; Song X
Drug Des Devel Ther; 2022; 16():1011-1024. PubMed ID: 35411132
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine protects melanocytes from autoantibody-induced injury by reducing the binding of antigen-antibody complexes.
Li DG; Hu WZ; Ma HJ; Liu W; Yang QQ; Zhao G
Mol Med Rep; 2016 Aug; 14(2):1275-82. PubMed ID: 27277530
[TBL] [Abstract][Full Text] [Related]
3. The multi-targets mechanism of hydroxychloroquine in the treatment of systemic lupus erythematosus based on network pharmacology.
Xie B; Geng Q; Xu J; Lu H; Luo H; Hu Y; Song X
Lupus; 2020 Nov; 29(13):1704-1711. PubMed ID: 32854577
[TBL] [Abstract][Full Text] [Related]
4. PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum.
Le Poole IC; Boissy RE; Sarangarajan R; Chen J; Forristal JJ; Sheth P; Westerhof W; Babcock G; Das PK; Saelinger CB
In Vitro Cell Dev Biol Anim; 2000 May; 36(5):309-19. PubMed ID: 10937834
[TBL] [Abstract][Full Text] [Related]
5. Targets of hydroxychloroquine in the treatment of rheumatoid arthritis. A network pharmacology study.
Xie B; Lu H; Xu J; Luo H; Hu Y; Chen Y; Geng Q; Song X
Joint Bone Spine; 2021 Mar; 88(2):105099. PubMed ID: 33160044
[TBL] [Abstract][Full Text] [Related]
6. A Preliminary Study on the Therapeutic Effects of Hydroxychloroquine on Generalized Vitiligo.
Sazgarnia S; Layegh P; Darchini-Maragheh E; Sepehr V; Meshkat M; Fathi-Najafi S; Rahsepar S
Acta Dermatovenerol Croat; 2022 Nov; 30(3):146-150. PubMed ID: 36812271
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome and Differential Methylation Integration Analysis Identified Important Differential Methylation Annotation Genes and Functional Epigenetic Modules Related to Vitiligo.
Pu Y; Chen X; Chen Y; Zhang L; Chen J; Zhang Y; Shao X; Chen J
Front Immunol; 2021; 12():587440. PubMed ID: 33790887
[TBL] [Abstract][Full Text] [Related]
8. Baicalein protects human vitiligo melanocytes from oxidative stress through activation of NF-E2-related factor2 (Nrf2) signaling pathway.
Ma J; Li S; Zhu L; Guo S; Yi X; Cui T; He Y; Chang Y; Liu B; Li C; Jian Z
Free Radic Biol Med; 2018 Dec; 129():492-503. PubMed ID: 30342186
[TBL] [Abstract][Full Text] [Related]
9. Interaction mechanism between hydroxychloroquine sulfate and collagen: Insights from multi-spectroscopy, molecular docking, and molecular dynamic simulation methods.
Wang H; Rao P; Qiu Y; Xiang L
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Dec; 303():123155. PubMed ID: 37480720
[TBL] [Abstract][Full Text] [Related]
10. Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection.
Goldstein NB; Koster MI; Hoaglin LG; Wright MJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
Exp Dermatol; 2016 Oct; 25(10):805-11. PubMed ID: 27193292
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide reduces melanin synthesis in vitiligo melanocytes by regulating autophagy.
Sun L; Sun J; Huo X; Feng Q; Li Y; Xie X; Geng S
Exp Dermatol; 2022 Oct; 31(10):1579-1585. PubMed ID: 35733278
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N;
JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340
[TBL] [Abstract][Full Text] [Related]
13. 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo.
Kroll TM; Bommiasamy H; Boissy RE; Hernandez C; Nickoloff BJ; Mestril R; Caroline Le Poole I
J Invest Dermatol; 2005 Apr; 124(4):798-806. PubMed ID: 15816839
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Different Genes Expressions during Immunological and Inflammatory Responses in Vitiligo.
Sharma CK; Sharma M; Prasad K
Crit Rev Eukaryot Gene Expr; 2017; 27(3):277-287. PubMed ID: 29199612
[TBL] [Abstract][Full Text] [Related]
15. Role of IL-17A receptor blocking in melanocyte survival: A strategic intervention against vitiligo.
Bhardwaj S; Bhatia A; Kumaran MS; Parsad D
Exp Dermatol; 2019 Jun; 28(6):682-689. PubMed ID: 30120811
[TBL] [Abstract][Full Text] [Related]
16. RNA-seq Reveals Dysregulation of Novel Melanocyte Genes upon Oxidative Stress: Implications in Vitiligo Pathogenesis.
Sastry KS; Naeem H; Mokrab Y; Chouchane AI
Oxid Med Cell Longev; 2019; 2019():2841814. PubMed ID: 31871544
[TBL] [Abstract][Full Text] [Related]
17. The multi-target mechanism of Cyclosporin A in the treatment of vitiligo based on network pharmacology.
Lu H; Xu J; Xie B; Hu Y; Luo H; Chen Y; Song X
Dermatol Ther; 2021 Jul; 34(4):e15023. PubMed ID: 34089287
[TBL] [Abstract][Full Text] [Related]
18. Suppression of FADS1 induces ROS generation, cell cycle arrest, and apoptosis in melanocytes: implications for vitiligo.
Tang L; Li J; Fu W; Wu W; Xu J
Aging (Albany NY); 2019 Dec; 11(24):11829-11843. PubMed ID: 31866583
[TBL] [Abstract][Full Text] [Related]
19. Identification of Critical Biomarkers and Mechanisms of
Liang TS; Tang N; Xian MH; Wen WL; Huang CJ; Cai LH; Li QL; Wu YH
Clin Cosmet Investig Dermatol; 2023; 16():2061-2071. PubMed ID: 37575147
[TBL] [Abstract][Full Text] [Related]
20. Decreased methionine sulphoxide reductase A expression renders melanocytes more sensitive to oxidative stress: a possible cause for melanocyte loss in vitiligo.
Zhou Z; Li CY; Li K; Wang T; Zhang B; Gao TW
Br J Dermatol; 2009 Sep; 161(3):504-9. PubMed ID: 19558554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
